Hot Products

Basic Information

Post buying leads

Suppliers

Name	Carmetizide	EINECS	N/A
CAS No.	42583-55-1	Density	1.618g/cm³
PSA	N/A	LogP	N/A
Solubility	N/A	Melting Point	N/A
Formula	C10H12 Cl N3 O6 S2	Boiling Point	589.4°Cat760mmHg
Molecular Weight	369.807	Flash Point	310.3°C
Transport Information	N/A	Appearance	N/A
Safety	An experimental teratogen. When heated to decomposition it emits toxic fumes of Cl⁻, SO_x, and NO_x. See also ESTERS.	Risk Codes	N/A
Molecular Structure		Hazard Symbols	N/A
Synonyms	2H-1,2,4-Benzothiadiazine-3-carboxylicacid, 6-chloro-3,4-dihydro-2-methyl-7-sulfamoyl-, methyl ester, 1,1-dioxide(7CI); Carmetizide; DU 5747

Carmetizide Chemical Properties

Molecule structure of Carmetizide (CAS NO.42583-55-1) :

IUPAC Name: methyl 6-chloro-2-methyl-1,1-dioxo-7-sulfamoyl-3,4-dihydrobenzo[e][1,2,4]thiadiazine-3-carboxylate
Molecular Weight: 369.80178 g/mol
Molecular Formula: C₁₀H₁₂ClN₃O₆S₂
Density: 1.618 g/cm³
Boiling Point: 589.4 °C at 760 mmHg
Flash Point: 310.3 °C
Index of Refraction: 1.605
Molar Refractivity: 78.67 cm³
Molar Volume: 228.4 cm³
Polarizability: 31.18×10^-24 cm³
Surface Tension: 59.7 dyne/cm
Enthalpy of Vaporization: 87.96 kJ/mol
Vapour Pressure: 7.19E-14 mmHg at 25 °C
XLogP3-AA: 0.1
H-Bond Donor: 2
H-Bond Acceptor: 9
Rotatable Bond Count: 3
Exact Mass: 368.985604
MonoIsotopic Mass: 368.985604
Topological Polar Surface Area: 136
Heavy Atom Count: 22
Complexity: 655
Canonical SMILES: CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)C(=O)OC
InChI: InChI=1S/C10H12ClN3O6S2/c1-14-9(10(15)20-2)13-6-3-5(11)7(21(12,16)17)4-8(6)22(14,18)19/h3-4,9,13H,1-2H3,(H2,12,16,17)
InChIKey: PFRBORHNFYMVOA-UHFFFAOYSA-N

Carmetizide Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD	intraperitoneal	> 5gm/kg (5000mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.
mouse	LD	oral	> 10gm/kg (10000mg/kg)	KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.
mouse	LD	subcutaneous	> 5gm/kg (5000mg/kg)	KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.
rat	LD	intraperitoneal	> 5gm/kg (5000mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.
rat	LD	oral	> 10gm/kg (10000mg/kg)	KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.
rat	LD	subcutaneous	> 5gm/kg (5000mg/kg)	KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 7, Pg. 231, 1973.

Carmetizide Safety Profile

An experimental teratogen. When heated to decomposition it emits toxic fumes of Cl⁻, SO_x, and NO_x. See also ESTERS.

Carmetizide Specification

Carmetizide (CAS NO.42583-55-1) is also called 6-Chloro-3-carbomethoxy-3,4-dihydro-2-methyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide ; BRN 0715143 ; Carbomethoxythiazide ; Carmetizida ; Carmetizida [INN-Spanish] ; Carmetizidum ; Carmetizidum [INN-Latin] ; DU 5747 ; DU-5747 ; 2H-1,2,4-Benzothiadiazine-3-carboxylic acid, 7-(aminosulfonyl)-6-chloro-3,4-dihydro-2-methyl-, methyl ester, 1,1-dioxide ; Methyl 6-chloro-3,4-dihydro-2-methyl-7-sulfamoyl-2H-1,2,4-benzothiadiazine-3-carboxylate 1,1-dioxide . Carmetizide (CAS NO.42583-55-1) is low toxic. It will produce toxic nitrogen oxides, sulfur oxides and chlorine fumes by heat. So the storage environment should be ventilate, low-temperature and dry.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 42583-55-1